Literature DB >> 19101237

Medium term effects of different dosage of diuretic, sodium, and fluid administration on neurohormonal and clinical outcome in patients with recently compensated heart failure.

Salvatore Paterna1, Gaspare Parrinello, Sergio Cannizzaro, Sergio Fasullo, Daniele Torres, Filippo M Sarullo, Pietro Di Pasquale.   

Abstract

Studies have shown that patients with compensated heart failure (HF) receiving high diuretic doses associated with normal sodium diet and fluid intake restrictions demonstrated significant reductions in readmissions and mortality compared with those who received low-sodium diets, and over a 6-month observation period, a reduction in neurohormonal activation was also observed. The aim of this study was to evaluate the effects of different sodium diets associated with different diuretic doses and different levels of fluid intake on hospital readmissions and neurohormonal changes after 6-month follow-up in patients with compensated HF. Four hundred ten consecutive patients with compensated HF (New York Heart Association class II to IV) aged 53 to 86 years, with ejection fractions <35% and serum creatinine <2 mg/dl, were randomized into 8 groups: group A (n = 52): 1,000 ml/day of fluid intake, 120 mmol/day, and 250 mg furosemide twice daily; group B (n = 51): 1,000 ml/day of fluid intake, 120 mmol/day, and 125 mg furosemide twice daily; group C (n = 51): 1,000 ml/day fluid intake, 80 mmol/day, and 250 mg furosemide twice daily; group D (n = 51): 1,000 ml/day fluid intake, 80 mmol/day, and 125 mg furosemide twice daily; group E (n = 52): 2,000 ml/day fluid intake, 120 mmol/day, and 250 mg furosemide twice daily; group F (n = 50): 2,000 ml/day fluid intake, 120 mmol/day, and 125 mg furosemide twice daily; group G (n = 52): 2,000 ml/day fluid intake, 80 mmol/day, and 250 mg furosemide twice daily; and group H (n = 51): 2,000 ml/day fluid intake, 80 mmol/day, and 125 mg furosemide twice daily. All patients received the treatments >or=30 days after discharge and for 180 days afterward. Signs of HF, body weight, blood pressure, heart rate, laboratory parameters, electrocardiograms, echocardiograms, brain natriuretic peptide, aldosterone, and plasma renin activity were examined at baseline and 180 days later. Group A showed the best results, with a significant reduction (p <0.001) in readmissions, brain natriuretic peptide, aldosterone, and plasma renin activity compared with the other groups during follow-up (p <0.001). In conclusion, these data suggest that the combination of a normal-sodium diet with high diuretic doses and fluid intake restriction, compared with different combinations of sodium diets with more modest fluid intake restrictions and conventional diuretic doses, leads to reductions in readmissions, neurohormonal activation, and renal dysfunction.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 19101237     DOI: 10.1016/j.amjcard.2008.08.043

Source DB:  PubMed          Journal:  Am J Cardiol        ISSN: 0002-9149            Impact factor:   2.778


  43 in total

1.  Salt and water imbalance in chronic heart failure.

Authors:  Gaspare Parrinello; Daniele Torres; Salvatore Paterna
Journal:  Intern Emerg Med       Date:  2011-10       Impact factor: 3.397

Review 2.  The vulnerable phase after hospitalization for heart failure.

Authors:  Stephen J Greene; Gregg C Fonarow; Muthiah Vaduganathan; Sadiya S Khan; Javed Butler; Mihai Gheorghiade
Journal:  Nat Rev Cardiol       Date:  2015-02-10       Impact factor: 32.419

3.  Interaction between loop diuretic-associated mortality and blood urea nitrogen concentration in chronic heart failure.

Authors:  Jeffrey M Testani; Thomas P Cappola; Colleen M Brensinger; Richard P Shannon; Stephen E Kimmel
Journal:  J Am Coll Cardiol       Date:  2011-07-19       Impact factor: 24.094

4.  Flawed evidence should not derail sound policy: the case remains strong for population-wide sodium reduction.

Authors:  Lawrence J Appel; Paul K Whelton
Journal:  Am J Hypertens       Date:  2013-10       Impact factor: 2.689

Review 5.  New insights into combinational drug therapy to manage congestion in heart failure.

Authors:  Frederik Hendrik Verbrugge; Lars Grieten; Wilfried Mullens
Journal:  Curr Heart Fail Rep       Date:  2014-03

6.  The new heart failure diet: less salt restriction, more micronutrients.

Authors:  Michael B Rothberg; Senthil K Sivalingam
Journal:  J Gen Intern Med       Date:  2010-10       Impact factor: 5.128

Review 7.  Korean Guidelines for Diagnosis and Management of Chronic Heart Failure.

Authors:  Min-Seok Kim; Ju-Hee Lee; Eung Ju Kim; Dae-Gyun Park; Sung-Ji Park; Jin Joo Park; Mi-Seung Shin; Byung Su Yoo; Jong-Chan Youn; Sang Eun Lee; Sang Hyun Ihm; Se Yong Jang; Sang-Ho Jo; Jae Yeong Cho; Hyun-Jai Cho; Seonghoon Choi; Jin-Oh Choi; Seong Woo Han; Kyung Kuk Hwang; Eun Seok Jeon; Myeong-Chan Cho; Shung Chull Chae; Dong-Ju Choi
Journal:  Korean Circ J       Date:  2017-09-18       Impact factor: 3.243

8.  Gaps in the Heart Failure Guidelines.

Authors:  Bao Tran; Gregg C Fonarow
Journal:  Card Fail Rev       Date:  2015-04

Review 9.  Dietary Self-management in Heart Failure: High Tech or High Touch?

Authors:  Eloisa Colin-Ramirez; JoAnne Arcand; Justin A Ezekowitz
Journal:  Curr Treat Options Cardiovasc Med       Date:  2017-03

10.  Heart failure management in dialysis patients: Many treatment options with no clear evidence.

Authors:  Bethany Roehm; Gaurav Gulati; Daniel E Weiner
Journal:  Semin Dial       Date:  2020-04-13       Impact factor: 3.455

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.